Uni-Bio Science Group Past Earnings Performance

Past criteria checks 4/6

Uni-Bio Science Group has been growing earnings at an average annual rate of 62.6%, while the Biotechs industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 23.3% per year. Uni-Bio Science Group's return on equity is 31.6%, and it has net margins of 19.4%.

Key information

62.6%

Earnings growth rate

62.8%

EPS growth rate

Biotechs Industry Growth	17.0%
Revenue growth rate	23.3%
Return on equity	31.6%
Net Margin	19.4%
Last Earnings Update	30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Uni-Bio Science Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:UNBS.F Revenue, expenses and earnings (HKD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Jun 24	508	99	280	45
31 Mar 24	497	85	284	40
31 Dec 23	485	71	289	36
30 Sep 23	490	67	294	29
30 Jun 23	495	63	300	23
31 Mar 23	467	51	279	29
31 Dec 22	440	39	259	36
30 Sep 22	416	16	252	44
30 Jun 22	392	-7	245	53
31 Mar 22	373	-13	241	52
31 Dec 21	353	-20	237	50
30 Sep 21	326	-39	232	52
30 Jun 21	298	-58	228	54
31 Mar 21	254	-65	210	47
31 Dec 20	209	-71	192	41
30 Sep 20	194	-63	183	39
30 Jun 20	180	-54	173	38
31 Mar 20	195	-26	195	40
31 Dec 19	209	2	217	43
30 Sep 19	191	-14	212	43
30 Jun 19	173	-30	207	42
31 Mar 19	154	-85	203	43
31 Dec 18	135	-139	199	44
30 Sep 18	144	-224	200	43
30 Jun 18	153	-309	201	42
31 Mar 18	155	-294	187	42
31 Dec 17	156	-279	173	43
30 Sep 17	148	-172	167	35
30 Jun 17	140	-64	160	27
31 Mar 17	143	-60	162	23
31 Dec 16	146	-56	164	19
30 Sep 16	141	-56	151	20
30 Jun 16	135	-55	138	22
31 Mar 16	129	-58	137	19
31 Dec 15	123	-60	136	17
31 Dec 14	122	-57	158	7
30 Sep 14	110	-365	210	0
30 Jun 14	106	-366	203	0
31 Mar 14	103	-366	196	0

Quality Earnings: UNBS.F has a high level of non-cash earnings.

Growing Profit Margin: UNBS.F's current net profit margins (19.4%) are higher than last year (12.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: UNBS.F has become profitable over the past 5 years, growing earnings by 62.6% per year.

Accelerating Growth: UNBS.F's earnings growth over the past year (56.2%) is below its 5-year average (62.6% per year).

Earnings vs Industry: UNBS.F earnings growth over the past year (56.2%) exceeded the Biotechs industry 20%.

Return on Equity

High ROE: UNBS.F's Return on Equity (31.6%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/21 20:40
End of Day Share Price	2024/10/25 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Uni-Bio Science Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution